Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Microbot Medical Inc (NQ: MBOT ) 1.091 +0.020 (+1.92%) Streaming Delayed Price Updated: 10:57 AM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 71,951 Open 1.110 Bid (Size) 1.090 (27) Ask (Size) 1.100 (30) Prev. Close 1.070 Today's Range 1.081 - 1.110 52wk Range 0.8601 - 2.740 Shares Outstanding 14,398,964 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center Today 8:30 EDT As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial July 09, 2024 From Microbot Medical Inc. Via GlobeNewswire Performance YTD -18.01% -18.01% 1 Month +4.86% +4.86% 3 Month +21.17% +21.17% 6 Month -13.45% -13.45% 1 Year -59.31% -59.31% More News Read More Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial July 08, 2024 From Microbot Medical Inc. Via GlobeNewswire Looking Into Microbot Medical's Recent Short Interest February 02, 2024 Via Benzinga Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial July 03, 2024 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial June 20, 2024 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial June 17, 2024 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules June 04, 2024 From Microbot Medical Inc. Via GlobeNewswire Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket June 04, 2024 Via Benzinga Dow Dips Over 300 Points; GameStop Shares Spike Higher June 03, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session June 03, 2024 Via Benzinga Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules June 03, 2024 From Microbot Medical Inc. Via GlobeNewswire Crude Oil Down Over 3%; US Construction Spending Falls In May June 03, 2024 Via Benzinga Exposures Fossil Fuels Why Microbot Medical Stock Is Up June 03, 2024 Via Benzinga Exposures Product Safety Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May June 03, 2024 Via Benzinga Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial June 03, 2024 From Microbot Medical Inc. Via GlobeNewswire MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024 May 15, 2024 Via InvestorPlace Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™ April 29, 2024 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Shares Status Following Recent Geopolitical Events April 15, 2024 From Microbot Medical Inc. Via GlobeNewswire MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023 March 27, 2024 Via InvestorPlace Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US February 05, 2024 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters January 30, 2024 From Microbot Medical Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
